What You Need to Know Before Meeting Potential Users of Your Technology
13 September 2007
Prior to engaging in discussions with potential users of your nutraceutical technology, you need to have such persons or entities execute proper confidentiality, non-disclosure, non-circumvention, and non-solicitation agreements in order to adequately protect your company and its technology. In his byline on www.nutraingredients-usa.com, Foley’s Thomas James discusses the various types of documents that are vital to a nutraceutical company’s protection and the importance of executing them prior to your first meeting.
Click here for the full article.
Related Insights
20 December 2024
Health Care Law Today
GLP-1 Drugs: FDA “Re-Confirms” Decision Removing Tirzepatide from the Drug Shortage List
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming that the tirzepatide drug shortage has been resolved. This order revoked and replaced FDA’s October 2, 2024, decision on tirzepatide.
20 December 2024
Manufacturing Industry Advisor
Christmas Came Early: Justice Delivered in Supplier Dispute Over Unjust Enrichment
The AirBoss saga continues… This holiday season, AirBoss Flexible Products Co. received a monumental legal victory, righting a costly wrong in MSSC, Inc. v. AirBoss.
19 December 2024
Health Care Law Today
HIPAA Reproductive Health Care Amendments: Compliance in an Uncertain Enforcement Landscape
The amendments to the HIPAA Privacy Rule designed to protect reproductive health care information are under legal challenge as the compliance date quickly approaches.